Molnupiravir, the second oral antiviral medication approved for the treatment of COVID-19, has been approved in Singapore

Molnupravir, an antiviral agent, will be the second oral pharmaceutical licenced in Singapore for the treatment of adult COVID-19 patients, the Health Sciences Authority (HSA) said on Tuesday (Apr 19).

On Tuesday, the HSA granted interim approval for MSD's Lagevrio under the Pandemi...

Australia is buying 300,000 courses of Merck & Co's Covid-19 pill

Highlights

• Australia to buy 300,000 courses of Merck & Co's antiviral pill
• Currently Philippines is running trials on the pill

Scott Morrison announced that Australia will be buying 300,000 courses of Merck & Co's exp...